Acute severe asthma: oxygen and high dose beta agonist during transfer for all?

Cochrane, G M
January 1995
Thorax;Jan1995, Vol. 50 Issue 1, p1
Academic Journal
No abstract available.


Related Articles

  • TREATING ACUTE ASTHMA IN ADULTS. Forsch, Randall // Journal of Family Practice;Oct1996, Vol. 43 Issue 4, p339 

    This article focuses on the nebulized albuterol dosage and method of delivery for severe acute asthma in adults with reference to the article, Continuous vs. intermittent albuterol, at high and low doses, in the treatment of severe acute asthma, by M. Sherestha and K. Bidadi. Patients presenting...

  • Oxygen treatment for acute severe asthma. Inwald, David; Roland, Mark; Kuitert, Lieske; McKenzie, Sheila A; Petros, Andy // BMJ: British Medical Journal (International Edition);7/14/2001, Vol. 323 Issue 7304, p98 

    Discusses whether treatment with oxygen should be used in all cases of acute severe asthma in Great Britain, including those presenting in primary care. Methods; Results of treatment with salbutamol in children and adults; Deaths from asthma; Conclusion that oxygen before and after treatment...

  • Inhaled Beta Agonists and Exacerbation of CAD. Miller, Karl E. // American Family Physician;7/1/2002, Vol. 66 Issue 1, p148 

    Provides information on the potential adverse effect of inhaled beta agonists on the cardiovascular system. Background on the use of inhaled beta agonists to treat chronic obstructive pulmonary disease and asthma; Association between acute coronary syndromes and inhaled beta-agonist therapy;...

  • Should inhaled anticholinergics be added to beta2 agonists for treating acute childhood and... Plotnick, Laurie H.; Ducharme, Francine M. // BMJ: British Medical Journal (International Edition);10/10/98, Vol. 317 Issue 7164, p971 

    Examines whether adolescents and children with acute asthma can be successfully treated with beta 2 agonists containing inhaled anticholinergics. Investigation of treatment effects for dichotomous outcomes; Results of several randomized controlled trials on the addition of inhaled...

  • Do Children with Acute Asthma Benefit More from Anticholinergics and Beta2 Agonists than from Beta2 Agonists Alone? CLEARY-HAMMARSTEDT, CASEY; FLYNN, CHERYL A. // American Family Physician;2015 Special Issue, Vol. 91, p1 

    The article discusses a study on the therapeutic and adverse effects of adding inhaled anticholinergics to beta2 agonists in the treatment of acute pediatric asthma. Topics covered include group differences in lung function supporting combination therapy with anticholinergics and beta2 agonists,...

  • Treatment for acute asthma in the Emergency Department: practical aspects. URSO, D.L. // European Review for Medical & Pharmacological Sciences;2010, Vol. 14 Issue 3, p209 

    This article describes the management of acute asthma exacerbation in the Emergency Department (ED). An asthma exacerbation can be defined as clinical worsening of disease or an asymptomatic decrease in peak flows. Acute exacerbations of asthma may represent reactions to airway irritants or...

  • Prescriber and pharmacist responses to intervention letters for Connecticut Medicaid beneficiaries with asthma. Coleman, Craig I.; Reddy, Prabashni; Laster-Bradley, N. Michelle; Dorval, Sheila; Munagala, Bharathi; White, C. Michael // American Journal of Health-System Pharmacy;6/1/2003, Vol. 60 Issue 11, p1142 

    Focuses on prescriber and pharmacist responses ton intervention letters for Connecticut Medicaid beneficiaries with asthma. Asthma guidelines of the United States National Institutes of Health; Use of high dose beta agonist.

  • Asthma. Fitzgerald, J. Mark; Dennis, Rodolfo J.; Solarte, Ivan // American Family Physician;7/1/2004, Vol. 70 Issue 1, p143 

    Presents information on the effectiveness of several treatments of asthma. Description of treatments that will be most beneficial for chronic asthma, including the addition of long-acting inhaled beta2 agonists ; Analysis of various treatments; Treatments for acute asthma and their...

  • The 'Crashing Asthmatic'. HIGGINS, JAMES C. // American Family Physician;2015 Special Issue, Vol. 91, p1 

    Asthma is a common chronic disorder, with a prevalence of 8 to 10 percent in the U.S. population. From 5 to 10 percent of patients have severe disease that does not respond to typical therapeutic interventions. To prevent life-threatening sequelae, it is important to identify patients with...

  • Overcoming beta-agonist tolerance: high dose salbutamol and ipratropium bromide. Two randomised controlled trials. Haney, Sarah; Hancox, Robert J. // Respiratory Research;2007, Vol. 8, p19 

    Background: Asthmatics treated with long-acting beta-agonists have a reduced bronchodilator response to moderate doses of inhaled short acting beta-agonists during acute bronchoconstriction. It is not known if the response to higher doses of nebulised beta-agonists or other bronchodilators is...


Read the Article


Sign out of this library

Other Topics